HomeUNCY • NASDAQ
add
Unicycive Therapeutics Inc
Previous close
$0.60
Day range
$0.55 - $0.62
Year range
$0.20 - $1.82
Market cap
59.56M USD
Avg Volume
1.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.25M | 5.27% |
Net income | -4.10M | 5.47% |
Net profit margin | — | — |
Earnings per share | -0.05 | 61.54% |
EBITDA | -6.24M | -5.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.35M | 125.49% |
Total assets | 38.57M | 98.41% |
Total liabilities | 10.72M | -33.01% |
Total equity | 27.85M | — |
Shares outstanding | 103.80M | — |
Price to book | 2.16 | — |
Return on assets | -37.53% | — |
Return on capital | -51.55% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -4.10M | 5.47% |
Cash from operations | -9.25M | -109.23% |
Cash from investing | -24.00K | — |
Cash from financing | -157.00K | -207.84% |
Net change in cash | -9.43M | -110.89% |
Free cash flow | -9.14M | -140.53% |
About
Founded
2016
Website
Employees
14
